← Back to Search

MuST AKT for Kidney Transplant (MuST AKT Trial)

N/A

Waitlist Available

Led By Dr. Shojai

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

English speaking

No obvious contraindication to kidney transplantation

Must not have

Candidate for multi-organ transplant

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from start date to end date of study recruitment, up to 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new intervention to help patients with kidney failure identify and communicate with potential living donors. The intervention includes support from a multidisciplinary team to educate the patients' social network. The goal is to increase living kidney donations by 34%.

Who is the study for?

This trial is for English-speaking patients with kidney failure who have completed an 'introduction to kidney transplant' module and are eligible for a transplant. It's not for those who've had previous transplants, have high psychosocial risk scores, already identified a donor, can't read basic health-related English or need multiple organ transplants.

What is being tested?

The MuST AKT intervention is being tested to see if it helps patients with kidney failure find living kidney donors by providing personalized support from a multidisciplinary team to educate their social networks about donation.

What are the potential side effects?

Since the intervention involves educational and support services rather than medication, traditional side effects are not applicable. However, participants may experience emotional or psychological stress during the process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I speak English.

Select...

I am a suitable candidate for a kidney transplant.

Select...

I have completed the kidney transplant introduction module.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am eligible for a transplant involving multiple organs.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from start date to end date of study recruitment, up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from start date to end date of study recruitment, up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and from start date to end date of study recruitment, up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Living Kidney Donor Evaluation Started

Secondary study objectives

Contact Living Donor Services

Identified potential advocates

Living Kidney Donor Evaluation Completed

+1 more

Other study objectives

Advocate and donor attendance at last intervention session

Consent rate

Conversation started

+8 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

This arm will receive the MuST AKT intervention, which is a multidisciplinary, tailored person-centered behavioural intervention designed to "help and enable" the potential kidney transplant recipients to achieve what is required to receive a living donor kidney transplantation.

Group II: Usual Care (control)Active Control1 Intervention

In the usual care (control) condition, participants will go through the current standard of care, which is a social worker assessment.

0 / 4Eligibility criteria met